§ Why is JNJ moving today →

Why Johnson & Johnson (JNJ) Stock Fell 2.0% on November 19, 2026

-2.04%$267.14November 19, 2026 · S&P 500 -1.96%
The short answer

Johnson & Johnson (JNJ) stock is down 2.0% to $267.14 in the November 19, 2026 session, mirroring a similar drop in the S&P 500 ETF (SPY), which is also down 2.0%. The broad market moved in the same direction by a similar amount, so the move is largely market-wide. Recent headlines, such as "Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?" and "Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue," do not clearly explain the stock's decline. Thus, there is no single clear catalyst in the news.

The news behind it

Johnson & Johnson vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027? · The Motley Fool · Nov 17
Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue · The Motley Fool · Nov 17
Before you buy or sell
Get a second opinion on JNJ
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when JNJ moves
Price, RSI and volume alerts by email or push. Free plan →

Full market recap for November 19, 2026 · What's moving JNJ today

Written from that session's quote and the headlines listed above. Educational, not financial advice.